CPIG
RYTM icon

Chicago Partners Investment Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Chicago Partners Investment Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,125
Closed -$266K – 1674
2026
Q1 		$266K Buy
3,125
+386
+14% +$37.5K 0.01% 1205
2025
Q4 		$282K Buy
2,739
+284
+12% +$30.1K 0.01% 1072
2025
Q3 		$279K Sell
2,455
-660
-21% -$61.3K 0.01% 994
2025
Q2 		$274K Sell
3,115
-395
-11% -$24.2K 0.01% 888
2025
Q1 		$227K Sell
3,510
-186
-5% -$10.3K 0.01% 807
2024
Q4 		$214K Sell
3,696
-1,029
-22% -$56.8K 0.01% 794
2024
Q3 		$232K Sell
4,725
-72
-2% -$3.45K 0.01% 707
2024
Q2 		$229K Sell
4,797
-648
-12% -$25.9K 0.01% 680
2024
Q1 		$218K Buy
+5,445
New +$238K 0.01% 672
2022
Q3 		– Sell
-12,821
Closed -$162K – 622
2022
Q2 		$162K Buy
12,821
+423
+3% +$2.31K 0.01% 557
2022
Q1 		$39K Buy
+12,398
New +$109K ﹤0.01% 555
2021
Q1 		– Sell
-6,253
Closed -$247K – 532
2020
Q4 		$247K Buy
+6,253
New +$159K 0.02% 400

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Chicago Partners Investment Group's RYTM Position: Q2 2026 in Review

Chicago Partners Investment Group sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2026, closing a stake of 3,125 shares — an estimated $266K sold.

Chicago Partners Investment Group first reported a position in RYTM in Q4 2020 and held it in 12 quarters. The position peaked at $282K in Q4 2025. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Chicago Partners Investment Group reported no remaining Rhythm Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Chicago Partners Investment Group sold 3,125 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $266K.
  • Chicago Partners Investment Group first reported a position in Rhythm Pharmaceuticals in Q4 2020 and held it in 12 quarters.
  • Chicago Partners Investment Group's Rhythm Pharmaceuticals position peaked at $282K in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.